Since TGFβ1 acts as a tumor promoter in late-stage tumorigenesis by increasing angiogenesis and metastasis, lowering the level of TGFβ1 leads to inhibition of cancer cell proliferation. This evidence concerns the gene TGFB1 and cancer.